Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-187610
Filing Date
2024-07-29
Accepted
2024-07-29 16:31:51
Documents
3
Group Members
CANAAN PARTNERS XII LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d856817dsc13g.htm SC 13G 71043
2 EX-24 d856817dex24.htm EX-24 13436
3 EX-99.1 d856817dex991.htm EX-99.1 4979
  Complete submission text file 0001193125-24-187610.txt   91212
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88806 | Film No.: 241152866
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 (203) 855-0400
Canaan XII L.P. (Filed by) CIK: 0001809934 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G